Degradation of pharmaceutical compounds in water by non-thermal plasma treatment.

Pharmaceutical compounds became an important class of water pollutants due to their increasing consumption over the last years, as well as due to their persistence in the environment. Since conventional waste water treatment plants are unable to remove certain non-biodegradable pharmaceuticals, advanced oxidation processes was extensively studied for this purpose. Among them, non-thermal plasma was also recently investigated and promising results were obtained. This work reviews the recent research on the oxidative degradation of pharmaceuticals using non-thermal plasma in contact with liquid. As target compounds, several drugs belonging to different therapeutic groups were selected: antibiotics, anticonvulsants, anxiolytics, lipid regulators, vasodilatators, contrast media, antihypertensives and analgesics. It was found that these compounds were removed from water relatively fast, partly degraded, and partly even mineralized. In order to ensure the effluent is environmentally safe it is important to identify the degradation intermediates and to follow their evolution during treatment, which requires complex chemical analysis of the solutions. Based on this analysis, degradation pathways of the investigated pharmaceuticals under plasma conditions were suggested. After sufficient plasma treatment the final organic by-products present in the solutions were mainly small molecules in an advanced oxidation state.

Degradation of pharmaceutical compound pentoxifylline in water by non-thermal plasma treatment.

The decomposition of a model pharmaceutical compound, pentoxifylline, in aqueous solution was investigated using a dielectric barrier discharge (DBD) in coaxial configuration, operated in pulsed regime, at atmospheric pressure and room temperature. The solution was made to flow as a film over the surface of the inner electrode of the plasma reactor, so the discharge was generated at the gas-liquid interface. Oxygen was introduced with a flow rate of 600sccm. After 60min plasma treatment 92.5% removal of pentoxifylline was achieved and the corresponding decomposition yield was 16g/kWh. It was found that pentoxifylline degradation depended on the initial concentration of the compound, being faster for lower concentrations. Faster decomposition of pentoxifylline could be also achieved by increasing the pulse repetition rate, and implicitly the power introduced in the discharge, however, this had little effect on the decomposition yield. The degradation products were investigated by liquid chromatography-mass spectrometry technique (LC-MS). The evolution of the intermediates during plasma treatment showed a fast increase in the first 30min, followed by a slower decrease, so that these products are almost completely removed after 120min treatment time.